NASDAQ · Healthcare · Biotechnology
Nuvectis Pharma, Inc.
NVCT
Nuvectis Pharma, Inc. CEO Ron Bentsur · Market cap $617.6M.
$23.27
-0.06 · -0.24%
52w hi $29.2752w lo $5.55
Off 52w high 33.3%
69
NOTABLE
Current InsiderScore
Corp · 90d
2
2 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
4
0 strong · 4 notable
Analyst consensus
Strong Buy
Avg PT $39.00
Section 01
Recent Form 4 filings
17 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Jun 30 | Marlio Charles Mosseri | Buy | 50,000 | $18.32 | +$916K | 67 | |
| Jun 30 | Ron Bentsur | Chairman & CEO | Buy | 12,500 | $20.00 | +$250K | 69 |
| Nov 05 | Ron Bentsur | Chairman & CEO | Buy | 5,000 | $5.72 | +$29K | 61 |
| Nov 05 | Juan Sanchez | Buy | 13,000 | $5.79 | +$75K | 60 | |
| Nov 05 | Matthew L. Kaplan | Buy | 11,000 | $5.84 | +$64K | 57 | |
| Oct 27 | Marlio Charles Mosseri | Buy | 72,836 | $6.28 | +$457K | 46 | |
| Oct 24 | Marlio Charles Mosseri | Buy | 35,034 | $6.15 | +$215K | 46 | |
| Oct 23 | Marlio Charles Mosseri | Buy | 46,900 | $6.06 | +$284K | 46 | |
| Jun 20 | Marlio Charles Mosseri | Buy | 5,603 | $7.99 | +$45K | 35 | |
| Jun 18 | Marlio Charles Mosseri | Buy | 28,043 | $8.05 | +$226K | 46 | |
| Jun 17 | Marlio Charles Mosseri | Buy | 5,399 | $8.11 | +$44K | 35 | |
| May 12 | Marlio Charles Mosseri | Buy | 21,167 | $8.11 | +$172K | 46 | |
| May 09 | Marlio Charles Mosseri | Buy | 9,850 | $8.95 | +$88K | 37 | |
| May 09 | Marlio Charles Mosseri | Buy | 9,817 | $8.90 | +$87K | 37 | |
| May 09 | Marlio Charles Mosseri | Buy | 5,395 | $8.98 | +$48K | 35 | |
| May 07 | Marlio Charles Mosseri | Buy | 9,614 | $8.64 | +$83K | 37 | |
| May 06 | Marlio Charles Mosseri | Buy | 10,104 | $8.64 | +$87K | 37 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
SepOctNovDecJanFebMarAprMayJunJulAug